We do not earn a commission from this provider.
NativeMed review
Graded on whether a price is published, checkable, and still true at month two — how we grade · how we verify prices
NativeMed's semaglutide card says $149. Click the monthly tab and it is $179; tirzepatide goes from $183 to $259. Both headlines are three-month prepay rates.
The $149 is the three-month starter billed $449 upfront. The month-to-month rate is $179 and it does not render until the MONTHLY tab is clicked.
- Advertised $149, actually $179
- Month-to-month price published
- States not published
- FDA warning letters: 0 of 0 matched
- Prices read September 2026
Read first-hand, not from a feed.
Distinct plans priced.
Added by the time you're billed.
This link pays us nothing. It's here because the price is checkable.
The verdict
The real month-to-month rate exists and is fair. It just is not the number on the card, and it renders only after you click something.
This link pays us nothing. It's here because the price is checkable.
Quick facts
Key facts
- Semaglutide, month to month
- $179, first month $159
- Semaglutide, three-month starter
- $149 a month, $449 upfront
- Tirzepatide, month to month
- $259, first month $199
- Tirzepatide, three-month starter
- $183 a month, $549 upfront
- NAD+ injection
- $189 monthly, or $159 on the three-month plan
- Price by dose?
- No. Same price at every dose
- States served
- Not published on any page we read
Pros and cons
What we like
- The struck-through regular prices are shown, not implied: $299 for semaglutide and $399 for tirzepatide sit beside the sale figures.
- The month-to-month rate does exist, and it names its own first-month discount rather than burying it.
- The NAD+ page prints its monthly plan at $189 and its three-month plan at $159 together, with the $479 total attached.
- The terms of service name the company and a Miami street address, which is more than half this batch manages.
What could be better
- Both GLP-1 cards lead with a prepay rate. The one-month figure is behind a tab that renders nothing until it is clicked.
- The tirzepatide gap is $183 advertised against $259 actual — the largest advertised-to-actual spread in this batch.
- No state list anywhere, and no statement of where the pharmacy network can ship.
- The homepage sale banner promises savings without naming the rate the saving is measured against.
What it is
A compounded GLP-1 seller with a short catalog — semaglutide, tirzepatide, NAD+, and three generics — sold as monthly subscriptions with the provider visit folded in. It is the compounded side of this market rather than the branded pens, and it says so on every product page.
Everything is priced per product rather than per dose, and the pages say the price holds at any dose. The NAD+ line runs beside the weight-loss one on the same checkout.
Every price we found
| Plan | Advertised | What you actually pay | The gap | Read on |
|---|---|---|---|---|
| Compounded semaglutide, month to monthCancel anytime. First month $159. The $149 belongs to the three-month starter. | $149 | $179 | September 2026 | |
| Compounded semaglutide, three-month starter$449 paid upfront for three months. | not published | $149 | not comparable | September 2026 |
| Compounded tirzepatide, month to monthCancel anytime. First month $199. | $183 | $259 | September 2026 | |
| Compounded tirzepatide, three-month starter$549 paid upfront for three months. | not published | $183 | not comparable | September 2026 |
| NAD+ injectionMonthly. The three-month plan is $479, which the page prints as $159 a month. | not published | $189 | not comparable | September 2026 |
This link pays us nothing. It's here because the price is checkable.
What it actually costs
The $149 on the semaglutide card is the three-month starter, billed $449 upfront. Month to month is $179, with a $159 first month, and that number renders only after the MONTHLY tab is clicked.
Tirzepatide splits the same way and wider: $183 advertised, $549 upfront for three months, against $259 a month with a $199 first month. That is a prepay rate wearing a monthly label all over again.
NAD+ is handled better. Its plan block prints $189 a month and $159 a month on the three-month plan at $479 side by side, with no clicking required.
Who it's wrong for
- Skip it if you want to try one month and stop. The one-month rate is the most expensive one here, and it is the one the site works hardest not to show you.
- Skip it if you need to know your state is covered. No state list appears on any of the five pages we read, and how many sellers publish one at all is the census we run.
- Skip it if you would rather have both terms on screen at once. Nouri prints all three of its plan lengths together with their totals.
Medications available
- Compounded semaglutideCompounded$179 a month, or $149 on the three-month starter
Same price at every dose. First month $159 on the monthly plan.
- Compounded tirzepatideCompounded$259 a month, or $183 on the three-month starter
First month $199 on the monthly plan.
- NAD+ injectionCompounded$189 a month
One concentration. The three-month plan is $479.
Is NativeMed legit?
NativeMed is operated by NativeMed, LLC., 66 W Flagler Street, Suite 900, Miami, FL 33130. We read that off the company’s own terms of service on September 2026.
What that means
A known-positive control passed in the same run, so a real match would have surfaced. A letter would be worth knowing about; it would not by itself disqualify a seller.Pharmacy, prescribers and safety checks
- Who prescribesNetwork providers, named as a separate medical practice in the terms
- Pharmacy namedNot disclosed. The pages say only that pharmacies are accredited
- Lot testingThe NAD+ page states potency, sterility, pH and endotoxin testing by registered labs
- Compounded disclosurePresent. The FDA does not review compounded medications, stated on the product page
- States servedNot published
Common questions
How much is NativeMed semaglutide per month?
$179 a month if you pay monthly, with a $159 first month. The $149 the product card advertises is the three-month starter plan, billed $449 upfront.
Why does the price change when I click a different tab?
The card defaults to the three-month starter. Clicking MONTHLY replaces the number with the month-to-month rate, which is $179 for semaglutide and $259 for tirzepatide.
Does the price go up as my dose increases?
No. Both GLP-1 pages state the same price applies at every dose, and no dose ladder appears anywhere on the pages we read.
Which states does NativeMed serve?
It does not say. We read five pages, including both GLP-1 product pages and the terms of service, and none of them names a state or describes where it can ship.
Why we gave NativeMed a C
Read the full grading rationale
Both GLP-1 product cards lead with a figure that is not a monthly price. Semaglutide shows $149 and tirzepatide $183; those are three-month starter plans billed $449 and $549 upfront, and the page says so beside the number. What it does not show is the month-to-month rate, which renders only after the MONTHLY tab is clicked: $179 for semaglutide with a $159 first month, $259 for tirzepatide with a $199 first month. Neither of those two figures is on the page a shopper lands on. Credit where it is due: the struck-through $299 and $399 are shown, the plan totals are shown, and the NAD+ page prints its monthly plan at $189 beside the three-month plan at $159 without hiding either. The legal entity and a Miami street address are both in the terms of service. No state list on the five pages read. FDA warning-letter screen on NativeMed, LLC. by domain and address: 0 of 0 matched, both controls passing in the same run.
How we reviewed NativeMed
- We read both GLP-1 product pages, the NAD+ page and the terms of service with a headless browser at desktop width, giving each page four and a half seconds to settle.
- The month-to-month figures were not in the page text on load. We clicked the MONTHLY tab on each GLP-1 page and read the number it revealed — one click, recorded on the capture.
- The legal entity and address come from the terms of service, and the FDA warning-letter screen was run against that domain and address with a known-positive and a known-negative control passing in the same run.
The 3 pages we read — all on
- Semaglutide page
SELECT PROGRAM 3 MONTH STARTER MONTHLY $328 LESS $149/mo | $449 PAID UPFRONT
- Tirzepatide page
SELECT PROGRAM 3 MONTH STARTER MONTHLY $508 LESS $183/mo | $549 PAID UPFRONT
- Nad page
Monthly PLAN NAD+ Ideal for both frequent users and those starting slower — one powerful concentration that fits all routines $189/mo
This link pays us nothing. It's here because the price is checkable.
Alternatives to NativeMed
| Provider | Grade | Cheapest price |
|---|---|---|
| Vytora Health | CCaveat | $149/mo |
| OurView Health | CCaveat | $99/mo |
| WeightCare | CCaveat | $215/mo |
| Coivas | CCaveat | $149/mo |
| Corsica Health | CCaveat | $149/mo |